EP4 receptor agonist, compositions and methods thereof

Details for Australian Patent Application No. 2002346561 (hide)

International Classifications

Event Publications

13 March 2003 Complete Application Filed

Priority application(s): 60/337,228 03.12.01 US

21 August 2003 Application Open to Public Inspection

Published as AU-B-2002346561

16 March 2006 Assignment before Grant

Merck & Co., Inc.; Merck Frosst Canada & Co. The application has been assigned to Merck & Co., Inc.; Merck Frosst Canada Ltd.

17 August 2006 Application Accepted

Published as AU-B-2002346561

14 December 2006 Standard Patent Sealed

25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.